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Introduction: A study of the whole spectrum of biopsied head and neck (HN) diseases in Taiwan has not yet been
performed. Therefore, the current study aimed to provide updated information about HN lesions in a cohort of
referral Taiwanese patients for histopathological examination.
Methods: HN lesions (2000–2011) in patients with records of age, sex, and histological diagnoses were retrieved
from the Oral Pathology Department of the institution. These lesions were classified into four main categories:
tumor/tumor-like reactive lesions, cystic/pseudocystic lesions, inflammatory/infective lesions, and others/
miscellaneous lesions.
Results: A total of 37,210 HN lesions were included in the current study. Most of these lesions were distributed in
the group of tumor/tumor-like reactive lesions, followed by the groups of inflammatory/infective lesions, cystic/
pseudocystic lesions, and others/miscellaneous lesions. Squamous cell carcinoma was the most common HN lesion,
and was also the most frequent malignant lesion among the referral patients.
Conclusion: It was worthy of note that squamous cell carcinoma and oral potentially malignant disorders
comprised high percentages of all HN lesions for the present cohort of referral patients.
Keywords: Oral lesions, Oral healthIntroduction
Reviewing the English literature, to our knowledge, most
of the previous studies of HN lesions analyzed specific
diseases, such as odontogenic cysts or tumors [1,2], in
certain populations, such as pediatric or geriatric popu-
lations [3,4]. There are only a few retrospective reports
focusing on the prevalence the whole spectrum of biop-
sied oral and maxillofacial (OMF) lesions in various
countries [5-11]. Information of the types and frequency
of HN lesions in the local population may always be
helpful in management the patients. A study of a variety
of biopsied HN diseases in Taiwanese patients has not
yet been performed. Hence, the present study aimed to
provide updated information about HN lesions in a* Correspondence: k840042@gmail.com
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unless otherwise stated.cohort of referral Taiwanese patients for histopathological
examination.Materials and methods
The Oral Pathology Department of the institution is the
department providing a histopathological service encom-
passed by HN surgery specialty in southern Taiwan,
receiving specimens mainly from the surgeons of the OMF
Surgery Department, ENT Department, and Plastic
Surgery Department of the hospital as well as other nearby
regional hospitals and local dental clinics. Three experi-
enced board-certified HN pathologists make the histo-
logical diagnosis for each biopsy independently, based
mostly on paraffin embedded sections of hematoxylin-
eosin staining and sometimes conjunction with im-
munohistochemical and/or histochemical staining. The
histological diagnoses are established by peer slide review;
however, if disagreement exists amongst the pathologists,
a consensus is reached upon mutual discussion.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 2 Number and percentages of the four categories
of head & neck lesions




Odontogenic (benign) 456 1.23
Non-odontogenic (benign)
Bone 160 0.43
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the data collected after the approval of the Institutional
Review Board of the hospital (KMUH-IRB-2014-73). A
total of 39,503 diagnosed cases in the HN region between
2000 and 2011 were retrieved from the database of the
Oral Pathology Department. With the exclusion of normal
tissues and lesions without specific findings, a pool of
37,210 cases was included for analyses. Age, sex, and
histological diagnoses were recorded for these HN lesions,
which were classified into four main categories: tumor/
tumor-like reactive lesions, cystic/pseudocystic lesions,
inflammatory/infective lesions, and others/miscellaneous
lesions.
Statistical analyses (chi-square test/binominal propor-
tion test) for prevalence rates of the lesions, age and sex
distributions of the patients were performed using SAS
Statistical Package (Version 9.1.3, SAS Institute Inc.,
Cary, NC, USA). Since the number of the items of some
tables was as large as approximately 50, we employed
the Bonferroni method (threshold of p = 0.001; p0/N,
p0 = 0.05, N = 50 items) for multiple testing-adjusted cor-
rections. Hence, the results were considered significant
when the p value was < 0.001 (i.e. 0.05/50). If p < 0.0001,
the research findings were very highly significant.
Results
The frequencies of the 12 most common HN lesions, with
a total number of 28,783, comprised 77.3% of all the le-
sions in the current study, are shown in Table 1. The most
common disease in the present cohort was squamous cell
carcinoma (SCC, 13.3%), followed by hyperkeratosis (HK,
12.8%), epithelial dysplasia (ED, 7.8%), candidiasis (6.8%),
oral submucous fibrosis (OSF, 6.7%) and epithelial
hyperplasia (EH, 6.4%); the aforementioned first sixTable 1 Number and percentages of the 12 most
common head & neck lesions
12 most common lesions Number % of all lesions
Squamous cell carcinoma 4960 13.3
Hyperkeratosis* 4779 12.8
Epithelial dysplasia* 2899 7.8
Candidiasis 2535 6.8
Oral submucous fibrosis* 2500 6.7
Epithelial hyperplasia* 2371 6.4
Verrucous hyperplasia* 1850 5.0
Inflammation 1821 4.9
Radicular cyst 1720 4.6
Apical granuloma 1395 3.8
Non-specific ulcer 986 2.6
Mucocele 967 2.6
Total number 28783 77.3
*Oral potentially malignant disorders.most common lesions constituted more than 50% of all
the HN lesions. With the exception of HK, the percent-
age of SCC was significant higher than ED, candidiasis,
OSF, and EH (p < 0.0001).
Various groups of HN lesions are classified in Table 2.
The highest number of lesions were distributed in the
group of oral potentially malignant disorders (38.7%),
followed by the groups of inflammatory/infective lesions
(31.6%) and non-odontogenic malignant lesions (16.2%).
In contrast, the lowest number of lesions was found in the
non-odontogenic cystic/pseudocystic group, in which only
91 cases were included. The percentage of oral potentially
malignant disorders was significant higher than inflamma-
tory/infective lesions and non-odontogenic malignant le-
sions (p < 0.0001). Also, the percentage of inflammatory/
infective lesions was significant higher than and non-
odontogenic malignant lesions (p < 0.0001).
The sex and age distribution of the HN lesion patients
is shown in Table 3. Most lesions were distributed in
the range of 50–59 years, followed by 40–49 years, and
30–39 years, all of which comprised more than 70.0% of
all HN lesions. The percentage of the patients in the range
of 50–59 years was significantly higher than the ranges
of 40–49 years and 30–39 year respectively (p < 0.0001)
whilst the percentage of the range of 40–49 year wasSalivary gland 96 0.26
Epithelial 118 0.32



















Table 3 Age and sex distribution of the patients
presenting head & neck lesions
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Moreover, in the above three age groups, the number of
male patients was higher significantly than the number of
female patients, particularly in the highest male to female
ratio in the range of 40–49 years (p < 0.0001), whereas
the lowest male to female ratio was found in the range
of 90–99 years (p = 0.0023). The lowest number of lesions
was found in the range of 90–99 years.
The data of the odontogenic cyst group are presented
in Table 4, with a male to female ratio of about 1.3:1.
(p < 0.0001). Radicular cyst was the most common le-
sion, comprising about 75.0% of the lesions within this
group, and was mostly distributed in the third to the
sixth decades of life significantly higher than other
groups (p < 0.0001). The second and the third most com-
mon lesions in this group were dentigerous cyst and kera-
tocystic odontogenic tumor (formerly called odontogenic
keratocyst), respectively; both lesions collectively com-
prised about 20.0% of the lesions. A significant difference





Radicular cyst 910 810 15 98 3
Dentigerous cyst 200 98 28 65 5
Keratocystic odontogenic tumor 106 64 4 40 4
Residual cyst 28 20 2 3
Calcifying odontogenic cyst 13 5 1 7
Paradental cyst 4 3 0 0
Glandular odontogenic cyst 4 0 0 0
Eruption cyst 4 0 1 3
Lateral periodontal cyst 2 2 0 0
Gingival cyst 1 0 1 0
Total 1272 1002 52 216 4cyst, dentigerous cyst and keratocystic odontogenic tumor
(p < 0.0001).
Only 91 cases were contained in the group of non-
odontogenic cystic/pseudocystic lesions (Table 5), with
a significant difference of male to female ratio of 2.8:1
(p < 0.0001). The most common lesion in this group was
epidermoid cyst, followed by lymphoepithelial cyst and
nasopalatine duct cyst. The percentage of epidermoid
cyst was significant higher than lymphoepithelial cyst
and nasopalatine duct cyst (p < 0.0001) whilst the per-
centage of lymphoepithelial cyst and nasopalatine duct
cyst was similar to each other (p < 0.4328). Most of the
epidermoid cysts were distributed in the range of 40–49
years, and the number of male patients was much
higher than that of female patients (p < 0.0001); the sec-
ond (lymphoepithelial cyst) and the third (nasopalatine
duct cyst) most common lesions were mostly found in
the first four decades of life.
The data of benign odontogenic tumors are listed
in Table 6, with a male to female ratio of almost 1:1
(p = 0.9254). The most common lesion within this group
was odontoma, comprising about 40.0% of the lesions,
which was predominantly found in the range of 10–19
years compared with the other groups (p < 0.0001). The
second most common lesion was ameloblastoma, which
was mostly distributed in the second and the third decade
of life. There were no significant differences between
odontoma and ameloblastoma (p = 0.0557).
Most of the HN lesions in the current study were dis-
tributed in the group of benign non-odontogenic tumor/
tumor-like reactive lesions (Table 7). The most common
lesion of this group was noted in the epithelial subgroup,
followed by the soft tissue subgroup, bone subgroup, and
salivary gland subgroup. The percentage of the epithelial
subgroup (n = 14,517) was significantly higher than the
soft tissue subgroup (n = 1,251), bone subgroup (n = 160),
and salivary gland subgroup (n = 96) (p < 0.0001). Also, thesenting odontogenic cysts
Age distribution (years)
-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
13 343 368 374 79 105 25 0
4 39 53 38 8 11 2 0
6 34 25 14 2 3 2 0
1 10 3 17 2 10 0 0
3 2 3 0 1 1 0 0
4 2 1 0 0 0 0 0
0 1 1 0 2 0 0 0
0 0 0 0 0 0 0 0
1 0 0 1 2 0 0 0
0 0 0 0 0 0 0 0
22 431 454 444 96 130 29 0
Table 5 Number, sex, and age distribution of the patients presenting non-odontogenic cyst/pesudocysts
Non-odontogenic
cyst/pesudocysts
Male Female Age distribution (years)
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Epidermoid cyst 34 7 0 2 4 6 16 6 3 3 1 0
Lymphoepithelial cyst 9 6 0 1 2 4 3 3 1 1 0 0
Nasopalatine duct cyst 7 4 0 0 2 2 1 4 2 0 0 0
Simple bone cyst 2 3 0 3 0 1 1 0 0 0 0 0
Aneurysmal bone cyst 4 0 0 0 3 0 0 1 0 0 0 0
Sebaceous cyst 2 1 0 0 2 0 1 0 0 0 0 0
Nasolabial cyst 2 1 0 0 0 0 1 2 0 0 0 0
Thyroglossal duct cyst 3 0 0 0 0 0 2 0 1 0 0 0
Incisive canal cyst 2 2 0 0 3 1 0 0 0 0 0 0
Branchial cleft cyst 1 0 0 0 0 0 0 0 0 1 0 0
Globulomaxillary cyst 1 0 0 0 0 1 0 0 0 0 0 0
Total 67 24 0 6 16 15 25 16 7 5 1 0
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significantly higher than the bone subgroup (n = 160),
and salivary gland subgroup (n = 96) (p < 0.0001). The
percentage of the bone subgroup (n = 160) was signifi-
cantly higher than the salivary gland subgroup (n = 96)
(p < 0.0001).
Five of the seven types of lesions in the epithelial sub-
group were potentially malignant disorders, and all
these five lesions belonged to the top 12 diseases. The
most common lesion of the potentially malignant disor-
ders was HK, followed by ED and OSF. The number of
male patients was almost ten times that of the female
patients in all the lesions of potentially malignant disor-
ders (p < 0.0001).
Fibroma, comprising about 50% of the lesions, was the
most common lesion in the soft tissue subgroup, signifi-
cantly higher than the other groups (p < 0.0001), with the
number of male patients almost equal to that of femaleTable 6 Number, sex, and age distribution of the patients pre
Odontogenic (benign) tumors Male Female
0-9 10-19
Odontoma 92 103 37 94
Ameloblastoma 92 67 5 14
Odontogenic fibroma 17 29 4 8
Odontogenic myxoma 11 9 0 8
Cementoblastoma 3 6 0 1
Adenomatoid odontogenic tumor 2 6 0 4
Ameloblastic odontoma 6 2 2 6
Calcifying epithelial odontogenic tumor 0 5 0 0
Ameloblastic fibroma 3 1 3 1
Squamous odontogenic tumor 1 1 1 0
Total 227 229 52 136patients (p= 0.9045). Hemangioma was the second most
common lesion, which was mostly found in the sixth dec-
ade of life. In the hemangioma, the percentage of sixth
decade of life was observed no significantly difference than
the age 40–49 (p = 0.0550). The 50–59 age group com-
pared with other groups, the p value was < 0.0001, except
for 30–39 age group (p = 0.0080), and 60–69 age group
(p = 0.0001).
Cemento-ossifying fibroma, cemento-osseous dyspla-
sia, and fibrous dysplasia, comprising about 76.0% of
the lesions, were the three most common lesions within
the bone subgroup, in which the number of males was
lower than that of females. The percentage of cemento-
ossifying fibroma was observed higher than cemento-
osseous dysplasia (p = 0.0171). Compared with fibrous
dysplasia, cemento-ossifying fibroma had higher per-
centage than fibrous dysplasia (p = 0.0019). There were
no difference of percentage between cemento-osseoussenting benign odontogenic tumors
Age distribution (years)
20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
29 14 7 12 2 0 0 0
42 35 24 27 11 1 0 0
12 9 5 4 2 2 0 0
5 1 4 0 0 2 0 0
0 2 3 1 1 0 1 0
0 2 2 0 0 0 0 0
0 0 0 0 0 0 0 0
1 0 4 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 1 0 0 0
89 63 49 44 17 5 1 0




Male Female Age distribution (years)
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Bone
Cemento-ossifying fibroma 18 40 0 2 9 22 15 8 0 2 0 0
Cemental-osseous dysplasia 2 33 0 4 4 3 9 10 4 1 0 0
Fibrous dysplasia 11 18 0 2 12 8 4 3 0 0 0 0
Osteoma 7 9 0 3 4 1 3 2 2 1 0 0
Central neurofibroma 1 3 0 0 0 2 0 2 0 0 0 0
Osseous choristoma 0 3 0 0 0 1 2 0 0 0 0 0
Central giant cell granuloma 2 1 1 0 1 0 0 1 0 0 0 0
Osteoblastoma 0 3 0 2 0 0 1 0 0 0 0 0
Central schwannoma 1 2 0 0 0 0 2 1 0 0 0 0
Desmoplastic fibroma 0 1 0 0 0 0 1 0 0 0 0 0
Osteolipoma 0 1 0 0 0 0 0 0 0 1 0 0
Chondroid choristoma 0 1 0 0 0 0 0 0 0 0 1 0
Ossifying fibromyxoid tumor 0 1 0 0 0 0 1 0 0 0 0 0
Juvenile aggressive ossifying fibroma 0 1 0 0 1 0 0 0 0 0 0 0
Synovial chondromatosis 0 1 0 0 0 0 0 0 1 0 0 0
Salivary gland
Pleomorphic adenoma 32 33 0 0 8 18 16 13 8 2 0 0
Warthin's tumor 10 2 0 0 0 0 2 7 2 1 0 0
Papillary cystic adenoma 4 4 0 0 3 0 0 2 0 3 0 0
Necrotizing sialometaplasia 3 1 0 0 0 1 1 1 1 0 0 0
Adenomatoid hyperplasia 2 0 0 0 1 0 0 1 0 0 0 0
Oncocytosis 1 1 0 0 0 0 1 1 0 0 0 0
Tubular adenoma 2 0 0 0 0 0 0 2 0 0 0 0
Benign lymphoepithelial lesion 1 0 0 0 0 0 0 0 0 1 0 0
Epithelial
Hyperkeratosis* 4294 485 4 29 252 938 1425 1444 438 216 31 2
Epithelial dysplasia* 2648 251 0 0 60 374 765 1053 364 237 44 2
Oral submucous fibrosis* 2330 170 0 11 171 534 741 701 247 93 2 0
Epithelial hyperplasia* 2088 283 3 14 95 376 646 801 243 169 23 1
Verrucous hyperplasia* 1726 124 1 2 33 308 572 599 157 169 8 1
Papilloma 74 41 0 4 12 15 31 33 7 9 4 0
Seborrheic keratosis 2 1 0 0 0 2 0 1 0 0 0 0
Soft tissue
Fibroma 311 314 20 20 64 112 158 170 35 33 12 1
Hemangioma 99 85 5 13 11 29 35 53 20 13 4 1
Fibrous hyperplasia 98 83 0 3 5 8 16 19 50 54 26 0
Lipoma 22 15 0 1 2 2 9 7 10 6 0 0
Verruca vulgaris 14 21 0 1 5 8 12 9 0 0 0 0
Peripheral odontogenic fibroma 7 22 0 1 5 7 10 6 0 0 0 0
Nevus 11 14 1 1 8 7 4 3 1 0 0 0
Lymphangioma 13 12 2 5 3 2 2 4 4 3 0 0
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Table 7 Number, sex and age distribution of patients presenting benign non-odontogenic tumor/tumor-like reactive
lesions (Continued)
Verruciform xanthoma 17 3 0 0 1 3 4 8 2 2 0 0
Myxofibroma 3 11 0 0 3 3 3 2 2 1 0 0
Schwannoma 5 6 1 4 2 3 0 1 0 0 0 0
Neurofibroma 7 5 0 0 2 0 5 4 1 0 0 0
Neuroma 3 5 0 1 0 1 1 3 2 0 0 0
Xanthogranuloma 2 5 0 0 1 1 0 5 0 0 0 0
Hemangioendothelioma 5 0 0 0 1 1 1 2 0 0 0 0
Granular cell tumor 2 3 0 0 3 1 1 0 0 0 0 0
Sclerosing hemangioma 2 2 0 0 0 0 3 1 0 0 0 0
Peripheral giant cell granuloma 3 0 0 0 0 0 1 1 0 0 1 0
Myofibroma 0 2 0 0 0 1 0 1 0 0 0 0
Keratoacanthoma 0 2 0 0 0 0 0 0 2 0 0 0
Peripheral odontogenic myxoma 1 1 0 0 0 0 0 0 1 1 0 0
Peripheral ossifying fibroma 0 2 0 0 0 0 1 1 0 0 0 0
Lipofibroma 1 1 0 0 0 0 1 1 0 0 0 0
Oral focal mucinosis 1 1 0 0 0 0 1 0 1 0 0 0
Neurofibromatosis 1 0 0 0 0 0 0 1 0 0 0 0
Angiofibroma 1 0 0 0 0 0 0 1 0 0 0 0
Fibrolipoma 1 0 0 0 0 0 1 0 0 0 0 0
Leiomyoma 1 0 0 0 0 0 0 1 0 0 0 0
Fibrous histiocytoma 1 0 0 0 0 0 1 0 0 0 0 0
Angiomyxoma 0 1 0 1 0 0 0 0 0 0 0 0
Lipoblastoma 1 0 0 1 0 0 0 0 0 0 0 0
Solitary fibrous tumor 0 1 0 0 0 1 0 0 0 0 0 0
Hemangiolymphangioma 0 1 0 0 1 0 0 0 0 0 0 0
Total 13892 2132 38 125 783 2793 4508 4990 1605 1018 156 8
*Oral potentially malignant disorder.
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ossifying fibroma, the percentage of males was significantly
lower than females (p = 0.0039). In cemento-osseous dys-
plasia, the percentage of males was significantly lower than
females (p < 0.0001). In fibrous dysplasia, the percentage
of males and females was similar (p = 0.1936).
Pleomorphic adenoma was the most common lesion
in the salivary gland subgroup compared with the other
type (p < 0.0001), with an almost equal sex distribution
(p = 0.9013); this comprised about 67.0% of the lesions
and was mostly noted in the fourth to the sixth decades
of life. Warthin’s tumor was the second most common
lesion, in which the number of males was much higher
than that of females (p = 0.0209).
The data of malignant non-odontogenic tumor/tumor-
like reactive lesions are shown in Table 8, with the number
of male patients being much higher than that of female
patients (12:1) (p < 0.0001); this was mostly located in
the fifth and sixth decades of life compared with theother the age groups (p < 0.0001). The highest number
of lesions was noted in the epithelial subgroup, in which
SCC predominated (82.0%), followed by verrucous car-
cinoma (6.5%). SCC had significant higher percentage
than the other types (p < 0.0001). The second highest
number of lesions was found in the salivary gland sub-
group, with mucoepidermoid carcinoma and adenoid
cystic carcinoma, comprising about 77.0% of all lesions,
being the two most common lesions. Mucoepidermoid
carcinoma had significant higher percentage than the
other types (p < 0.0001). Adenoid cystic carcinoma had
higher percentage than the other types (p = 0.0009). On
the other hand, the lowest number of lesions was found
in the mesenchymal subgroup, the most frequent lesion
being osteosarcoma, which comprised about 60.0% of the
lesions. Osteosarcoma had higher percentage than malig-
nant fibrous histiocytoma (p = 0.0348). The second lowest
number of lesions was noted in the hematologic subgroup,
in which non-Hodgkin’s lymphoma and Langerhans cell
Table 8 Number, sex and age distribution of patients presenting malignant non-odontogenic tumors
Non-odontogenic (malignant)
tumors
Male Female Age distribution (years)
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Mesenchymal
Osteosarcoma 3 6 0 3 0 0 0 3 1 1 1 0
Malignant fibrous histiocytoma 2 0 0 0 0 0 0 2 0 0 0 0
Malignant solitary fibrous tumor 1 0 0 0 0 1 0 0 0 0 0 0
Neuroblastoma 0 1 1 0 0 0 0 0 0 0 0 0
Ewing sarcoma 1 0 0 1 0 0 0 0 0 0 0 0
Chondrosarcoma 0 1 0 0 0 0 0 1 0 0 0 0
Hematologic
Non-Hodgkin's lymphoma 13 6 0 1 3 0 5 5 0 4 1 0
Langerhans cell histocytosis 12 0 0 0 2 6 2 2 0 0 0 0
Plasmacytoma 3 4 0 0 0 0 5 2 0 0 0 0
Leukemia 0 3 2 0 0 0 1 0 0 0 0 0
Hodgkin's lymphoma 1 1 0 0 0 0 0 0 0 2 0 0
Malignant hemangioendothelioma 0 1 0 0 1 0 0 0 0 0 0 0
Multiple myeloma 0 1 0 0 0 0 0 0 0 1 0 0
Salivary gland
Mucoepidermoid carcinoma 19 16 0 0 7 9 7 6 0 3 3 0
Adenoid cystic carcinoma 18 10 0 0 1 4 3 5 0 12 3 0
Papillary cystic adenocarcinoma 6 2 0 0 0 0 0 0 0 6 2 0
Adenocarcinoma, NOS 4 3 0 0 2 0 2 3 0 0 0 0
Salivary duct carcinoma 2 1 0 0 1 2 0 0 0 0 0 0
Acinic cell carcinoma 1 0 0 0 0 0 0 0 0 1 0 0
Epithelial
Squamous cell carcinoma 4628 332 0 0 49 603 1709 1735 439 350 71 4
Verrucous carcinoma 359 34 0 1 0 42 113 136 40 52 9 0
Metastatic carcinoma 319 29 0 0 0 46 137 128 22 14 1 0
Carcinoma in situ 142 13 0 0 1 23 40 53 18 16 4 0
Undifferentiated carcinoma 11 4 0 0 0 2 2 3 2 3 3 0
Spindle cell carcinoma 10 1 0 0 0 4 1 4 0 2 0 0
Carcinosarcoma 3 1 0 0 0 1 2 1 0 0 0 0
Total 5558 470 3 6 67 743 2029 2089 522 467 98 4
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the two most frequent lesions.
The second greatest number of HN lesions was noted
in the inflammatory/infective group (Table 9), which com-
prised about 31.8% of all the HN lesions, with a male to fe-
male ratio of about 1.7:1 (p < 0.0001). Candidiasis was the
most common lesion in this group, followed by inflamma-
tion, with both lesions being located in the range of 50–59
years. In candidiasis, the 50–59 years had significant
higher percentage than the other age groups (p < 0.0001).
In inflammation, the 50–59 years had significant higher
percentage than the other age groups (p < 0.0001), exceptfor 40–49 age group (p = 0.0112). Apical granuloma, dis-
tributed evenly in the fourth to the sixth decades of age,
was the third most common lesion in this group.
The data of the others/miscellaneous lesions are shown
in Table 10, with the number of female patients being
slightly higher than that of the male patients (p = 0.8660).
Exostosis, mostly distributed in the range of 50–59
years, was the most common lesion within this group
and comprised about 44.0% of the lesions. The exostosis
had the highest percentage than other types significantly
(p < 0.0001). Dense fibrotic dental follicle was the sec-
ond most common lesion, which occurred mostly in the
Table 9 Number, sex and age distribution of patients presenting inflammatory/infective lesions
Inflammatory/infective lesions Male Female Age distribution (years)
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Candidiasis 1908 627 13 8 52 290 614 872 328 275 79 4
Inflammation 1149 672 21 55 134 191 434 512 191 196 83 4
Apical granuloma 551 844 0 49 242 312 340 320 55 66 10 1
Non-specific ulcer 728 258 6 21 46 103 210 290 162 105 43 0
Mucocele 539 428 103 179 320 161 91 66 25 19 3 0
Lymphadenitis 539 43 1 1 14 86 228 179 62 9 2 0
Pyogenic granuloma 323 189 8 13 44 93 128 134 43 40 8 1
Granulation tissue 307 196 12 37 38 57 108 136 46 55 13 1
Lichen planus* 201 268 0 5 28 59 121 177 45 30 4 0
Osteomyelitis 141 145 0 3 10 19 45 76 39 64 25 5
Sequestrum 149 113 1 2 6 20 39 72 44 50 25 3
Sialadenitis 87 103 2 2 11 29 45 66 9 21 5 0
Scar tissue 145 32 2 9 7 26 49 49 15 16 3 1
Inflammatory fibrous hyperplasia 94 69 0 0 14 27 40 82 0 0 0 0
Apical scar 63 69 0 2 26 36 36 32 0 0 0 0
Acanthosis 89 12 0 2 5 30 27 37 0 0 0 0
Necrotic tissue 72 18 3 2 4 4 24 35 10 6 2 0
Mucositis 56 27 1 1 7 16 17 26 11 4 0 0
Osteoradionecrosis 53 4 0 0 0 3 11 30 4 7 2 0
Fibrosis 28 19 1 3 5 7 10 19 0 2 0 0
Foreign body granuloma 33 13 0 0 0 6 19 18 0 1 2 0
Ranula 20 18 0 2 16 6 3 11 0 0 0 0
Sinusitis 22 11 0 5 5 4 8 8 2 1 0 0
Sialoithiasis 20 9 0 0 8 2 4 10 1 4 0 0
Gingival hyperplasia 14 10 2 3 8 6 1 0 1 3 0 0
Osteosclerosis 9 14 0 1 7 3 5 7 0 0 0 0
Tuberculosis 16 5 3 0 2 3 2 4 2 3 2 0
Epulis granulomatosum 6 14 0 0 2 5 1 6 1 2 3 0
Pemphigus vulgaris* 14 6 0 1 0 1 9 5 4 0 0 0
Actinomycosis 9 8 0 2 0 2 2 5 1 5 0 0
Sjogren syndrome* 1 14 0 1 1 2 4 3 1 3 0 0
Periodontitis 8 6 0 1 1 1 5 3 1 2 0 0
Condensing osteitis 7 6 0 0 0 0 2 5 4 2 0 0
Gingivitis 7 5 0 0 0 3 2 5 2 0 0 0
Fistula 10 2 0 1 0 1 6 2 1 1 0 0
Pseudoepitheliomatous hyperplasia 6 2 0 0 0 0 2 6 0 0 0 0
Epulis fissuratum 5 3 0 0 0 0 0 0 6 2 0 0
Periapical abscess 6 1 0 0 0 0 0 6 1 0 0
Glossitis 0 6 0 0 0 1 0 3 0 2 0 0
Thrombus 3 3 0 1 0 0 2 1 2 0 0 0
Polyp 4 2 0 0 2 0 1 2 1 0 0 0
Pulp stone 2 2 0 0 2 0 0 2 0 0 0 0
Pulpitis 2 2 0 0 0 0 0 2 2 0 0 0
Lei et al. Head & Face Medicine 2014, 10:28 Page 8 of 13
http://www.head-face-med.com/content/10/1/28
Table 9 Number, sex and age distribution of patients presenting inflammatory/infective lesions (Continued)
Plasma cell granuloma 2 2 0 0 1 1 2 0 0 0 0 0
Amyloidosis 3 0 0 0 0 0 0 1 1 0 1 0
Pemphigoid 0 3 0 0 0 1 1 1 0 0 0 0
Paget's disease 2 0 0 0 0 0 0 2 0 0 0 0
Histioplasmosis 1 1 0 0 0 0 0 1 0 1 0 0
Herpes simplex infection 2 0 0 0 0 0 0 2 0 0 0 0
Pericornitis 2 0 0 0 0 0 0 2 0 0 0 0
Myositis 1 0 1 0 0 0 0 0 0 0 0 0
Phlebolith with thrombosis 0 1 0 0 0 0 0 0 1 0 0 0
Psoriasiform mucositis 1 0 0 0 0 0 1 0 0 0 0 0
Acanthosis nigricans 1 0 0 0 0 0 1 0 0 0 0 0
Tonsilitis 0 1 0 0 0 1 0 0 0 0 0 0
Chondroid hyperplasia 1 0 0 0 0 1 0 0 0 0 0 0
Nodular fascitis 1 0 0 0 0 0 0 1 0 0 0 0
Socket sclerosis 0 1 0 0 0 0 0 0 0 1 0 0
Caries 1 0 0 0 0 0 0 0 0 1 0 0
Varicosities 0 1 0 0 0 0 0 1 0 0 0 0
Lupus erythematosus 1 0 0 0 0 1 0 0 0 0 0 0
Sialodochitis 1 0 0 1 0 0 0 0 0 0 0 0
Phycomycosis 0 1 0 1 0 0 0 0 0 0 0 0
Total 7466 4309 180 414 1068 1620 2700 3335 1123 1000 315 20
*Autoimmune disease.
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licle had the highest percentage than the other types
significantly (p < 0.0001).
Discussion
The Oral Pathology Department not only provides ser-
vices for nearly all the biopsied HN lesions (Medical
Pathology contributes only a minor number of cases),
but is also the most heavily used referral center for pa-
tients with these lesions in southern Taiwan. Therefore,
the various types of lesions in the current study are rep-
resentative of the occurrence of such lesions among the
cohort of referral patients for a biopsy procedure in this
geographical region.
In the current study, a total of 37,210 cases of HN lesions
from 2000–2011 was documented in a cohort of Taiwanese
patients referred for histopathological examination. SCC
was the most common lesion in this cohort (13.3%),
which was in contrast to the findings of Franklin &
Jones [8] and Ali & Sundaram [9], in which fibrous
hyperplasia (14.7% and 20.7% respectively) was the most
common lesion, as well as different to the findings of
Bhasker [10] and Tay [11], in which dental granuloma
(11.1%) and fibrous epulis (10.3%) were respectively the
most frequent lesions. This may be due to the fact that
betel quid chewing, which is a high risk factor for oralepithelial malignancies, has a high incidence in Taiwan
[12]. This finding was consistent to the high incidence
(16.2–39.0%) of oral cancers in India [13], in which
betel quid chewing has been responsible for half of oral
cancer cases [14]. On the other hand, the prevalence of
OSF, being one of the oral potential malignant disorders
closely associated with betel quid chewing, of the
present study (6.7%) was compatible to that of the study
from India (7.1%) [15]. So, the high frequency of betel
quid chewing in Taiwan may also contribute to the find-
ing that five of the twelve most common lesions were
potentially malignant disorders in the present study.
However, it should be cautioned that the present cohort
consisted only of patients and such patients were much
more likely to be referred for histopathologcal assess-
ments; hence, a higher prevalence of SCC and oral po-
tentially malignant disorders would be expected to be
observed.
Most lesions in the current study were distributed in the
benign non-odontogenic tumor group (43.1%), followed
by the inflammatory/infective group (31.6%), which was
compatible with the findings of Jones & Franklin [6]. On
the other hand, the lowest numbers of lesions was in
the non-odontogenic cyst/pseudocyst group, which was
consistent with the other studies [7,10,11]. Moreover,
oral epithelial malignant lesions comprised 16.2% of all
Table 10 Number, sex and age distribution of patients presenting others/miscellaneous lesions
Others/miscellanous
lesions
Male Female Age distribution (years)
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Exostosis 119 142 1 4 9 41 56 99 14 34 3 0
Dense fibrotic dental follicle 57 59 26 50 30 5 3 2 0 0 0 0
Foreign body 34 15 0 2 3 3 18 15 5 3 0 0
Hematoma 20 15 0 1 2 3 7 10 4 6 2 0
Melanotic macule 8 17 0 0 5 6 3 9 0 1 1 0
Fordyce's granule 12 6 0 1 1 2 10 3 1 0 0 0
Hypercementosis 6 5 0 0 1 1 3 2 3 1 0 0
Supernumery tooth 5 5 3 3 2 1 0 1 0 0 0 0
Blood clot 6 3 0 1 1 0 1 1 1 2 2 0
Melanoplakia 3 4 0 1 2 3 0 1 0 0 0 0
Internal root resorption 1 3 0 2 1 0 0 0 0 1 0 0
Mesioden 1 3 2 2 0 0 0 0 0 0 0 0
Calcification 2 1 0 0 0 0 1 1 1 0 0 0
Osteoporosis 2 0 0 0 0 0 0 0 0 2 0 0
Dentinogenesis imperfecta 0 2 2 0 0 0 0 0 0 0 0 0
Melanosis 1 1 2 0 0 0 0 0 0 0 0 0
Leukoedema 1 0 0 0 0 1 0 0 0 0 0 0
Amalgum tatoo 0 1 0 0 0 0 0 0 1 0 0 0
Epithelial atrophy 1 0 0 0 0 0 0 0 0 1 0 0
Natal tooth 0 1 1 0 0 0 0 0 0 0 0 0
Total 279 283 37 67 57 66 102 144 30 51 8 0
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to be much higher than the data of Bhaska (6.9%) [10].
The overall male to female ratio (3.4:1) in the current
study was higher than the studies of Ali (1.1:1) [7], Ali &
Sundaram (1.1:1) [9], Akinmoladun et al. (1.2:1) [5], and
Jones & Franklin (0.9:1) [6]. Most lesions were located in
the range of 50–59 years, followed by 40–49 years,
which may be attributed to the aging population becom-
ing dominant in Taiwan [16]. Additionally, this finding
was in contrast to the study of Akinmoladun et al. in
Nigeria (range: 20–29 years) [5].
The lesions in the odontogenic cystic group were
mostly distributed in the third to the sixth decade of life,
and the number of males was slightly higher than the
number of females; this result was compatible with the
study of Avelar et al. [1]. Radicular cyst was the most
common (76.0%) of the lesions within the odontogenic
cyst group in this study; this finding was similar to other
studies [17-21]. Furthermore, most radicular cysts were
distributed in the maxilla (64.7%) in this cohort, which
was similar to the results of Souza et al. (63.0%) [21] and
Prockt et al. (66.0%) [20]. Dentigerous cyst was the sec-
ond most common lesion (13.1%), in which the ratio of
males to females was about 2:1; this was similar to the
study of Selvamani et al. [18]. More cases of dentigerouscyst were noted in Bhasker’s study (33.8%) [10] in com-
parison with the present study cohort. Additionally, al-
though the majority of dentigerous cysts were located in
the mandible (62.4%) in this study, this was lower than
the findings of Souza et al. (81.0%) [21] and Prockt et al.
(69.0%) [20]. Keratocystic odontogenic tumor was the
third most common lesion in this group (7.0%), which
was compatible with the study of Jones & Franklin [6];
however, this lesion was the most frequent in the study
of Koivisto et al. [22]. Moreover, most keratocystic
odontogenic tumors were located in the mandible in
this study cohort, similar to the results of the other
studies [18,19,21,22].
Epidermoid cyst was the most common lesion in the
group of non-odontogenic cyst/pseudocyst in the current
cohort, which was in contrast to the studies of Ali [7],
Bhasker [10] and Tay [11], in which nasopalatine duct cyst
was found to be the most common lesion respectively in
these three studies. Lymphoepithelial cyst and nasopala-
tine duct cyst were the second and the third most com-
mon lesions in this group, but the numbers of cases of
these two kinds of cyst were much lower than that of
epidermoid cyst.
Odontoma was the most common lesion in the group
of benign odontogenic tumor, constituting about 43.0%
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[7]. The ratio of compound to complex odontomas in
the current study (1.8:1) was compatible with the re-
sults of Bhaskar (2.1:1) [10] and Tay (2.4:1) [11] but in
contrast to the data of Jones & Franklin (1:1.6) [6] and
Luo & Li (1:1.4) [23]. Furthermore, most of the odonto-
mas were diagnosed in the second decade of life in the
study, which was the same as the result of Luo & Li [23].
Although the majority of odontomas in the present study
were located in maxilla (56.5%), this was lower than the
results of Servato et al. (66.6%) [2] and Luo & Li (66.0%)
[23]. Ameloblastoma was the second most common lesion
in the study, with a male to female ratio of 1.37:1, which
was compatible with the study of Siriwardena et al.
(1.03:1) [24], who reported the average age to be 37.5 years,
which was also compatible with the study (36.6 years).
Additionally, similar to the other studies [2,24-26], most
ameloblastomas in the present study were located in the
mandible. Odontogenic fibroma was the third most com-
mon lesion in this group, which was different to the stud-
ies of Bhaskar [10] and Tay [11], who reported that it was
the most common lesion. Most of the odontogenic fibro-
mas in our cohort were diagnosed in the third decade of
life, which was the same as the studies of Luo & Li [23]
and Servato et al. [2].
Pleomorphic adenoma (67.0%) and Warthin’s tumor
(12.5%) were the two most common lesions in the salivary
gland subgroup, which was compatible with the results of
Jaafari-Ashkavandi et al. (80.2% and 10.5%, respectively)
[27] and Wang et al. (52.7% and 17.4%, respectively) [28].
Most pleomorphic adenomas in the present study were
located in the palate (60.0%), followed by the parotid
gland (30.0%), which was different to the studies of
Jaafari-Ashkavandi et al. [27] and Wang et al. [28], in
which most cases were located in the parotid gland
(52.2% and 52.7%, respectively). Additionally, the male
to female ratio of the cases of pleomorphic adenoma
was almost 1:1 in the study, which was compatible with
the report of Jaafari-Ashkavandi et al. (1.26:1) [27]. On
the other hand, same as the study of Wang et al. [28],
most Warthin’s tumors in the present cohort were lo-
cated in the parotid gland. The male to female ratio of
Warthin’s tumors in the cohort was 5:1, which was
higher than the data of Wang et al. [28].
Fibroma was the most common lesion (69.4%) in the
soft tissue subgroup, which was compatible with the
studies of Ali & Sundaram [9] and Jones & Franklin [6].
Most of the fibromas in the current study were found
in the buccal mucosa; however, they most commonly
occurred in the gingiva/alveolar ridge in the study of
Ali & Sundaram [9]. Hemangioma was the second most
common lesion in the study, comprising cavernous
(60.0%) and capillary (40%) types, which was compatible
with the results of Jones & Franklin (62.0% and 38.0%,respectively) [6]. Furthermore, most of the hemangiomas
in the study were noted in the tongue, but no specific
location has been documented in other studies [5-11].
In the current study, the number of female patients
was about three times higher than that of male patients
(1 : 3) in the bone subgroup, which was similar to the re-
sult of Ali (1:8) [7]. Cemento-ossifying fibroma was the
most common lesion within this subgroup, which was in
contrast to the results of Ali [7], who reported central
giant cell granuloma to be the most common lesion. Most
cemento-ossifying fibromas were located in the mandible,
and were diagnosed most frequently in the fourth decade
of life in the current study, which was the same as the data
of MacDonald-Jankowski [29]. Cemento-osseous dysplasia
was the second most common lesion, most documented
in the fifth and sixth decades of life, and mostly in females;
all these findings were compatible with the study of
Alsufyani & Lam [30]. Additionally, most of these le-
sions were located in the mandible (83.0%), which was
similar to the study of Alsufyani & Lam (81.4%) [30].
The lesions within the epithelial subgroup comprised
about 39.0% of all HN lesions in the present cohort,
which was much higher than the result of Amarasinghe
et al. (11.3%) in Sri Lanka [31]. Furthermore, the number
of males was much greater than that of females in our
study, which was compatible with the reports of Ali &
Sundaram [9] and Thomas et al. [32]; however, an almost
equal sex distribution was reported in the study of Jones &
Franklin [6]. Worthy of note, five of the seven types of
lesions in this subgroup were potentially malignant dis-
orders, and were also categorized within the 12 most
common lesions; this may be due to the high frequency
of oral habits related to risk of oral malignancy in
Taiwan. Most of these five potentially malignant disor-
ders were documented in the fifth and sixth decades of
life, and most were found in the buccal mucosa, which
was compatible with the study of Thomas et al. [32].
HK was the most common lesion in the epithelial sub-
group, followed by ED in the current study, which was
compatible with the report of Jones & Franklin [6].
Compatible with the study of Ali [7], the number of le-
sions in the bone subgroup in this study was low, osteosar-
coma being the most common lesion, but only nine cases
were documented. On the other hand, only 0.7% of lesions
were noted in the hematologic subgroup, which was lower
than the study of Jones & Franklin [6].
Mucoepidermoid carcinoma and adenoid cystic carcin-
oma were the two most common malignant lesions in the
salivary gland subgroup, which was similar to the results
of Bradley & McGurk [33] and Wang et al. [28] but in
contrast with the findings of Jaafari-Ashkavandi et al.
[27]. The male to female ratio (1.6:1) in this subgroup
was compatible with the results of Zohreh et al. (1.2:1)
[27] and Wang et al. (1.2:1) [28]. Most mucoepidermoid
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palate, which was different to other studies [27,28,33].
Additionally, the mean age at which mucoepidermoid
carcinoma was diagnosed in our study (37.6 years) was
compatible with the study of Wang et al. (39.5 years)
[28]. On the other hand, most of the adenoid cystic car-
cinomas in our cohort were located in the submandibu-
lar gland, which was similar to the studies of Bradley
et al. [33] and Wang et al. [28]. Moreover, the mean age
(60.5 years) at which adenoid cystic carcinoma was di-
agnosed in the present study was seemed to be greater
than the result of Wang et al. (46 years) [28].
SCC was the most common HN lesion (13.3%) and
also the most frequent lesion in the epithelial subgroup
of malignant non-odontogenic tumors, which was ap-
peared to be higher than the findings of Jones & Franklin
[6] and Tay (3.5%) [11]. Most of the oral epithelial ma-
lignant lesions in the current study were located in the
buccal mucosa, which was different to the results of
Hernandez-Guerrero et al. [34] from Mexico, in which
tongue cancer was the most commonly documented
malignant lesion. The ratio of males to females in the
cohort was 13.9:1, which was seemed to be much higher
than the findings of the Internal Agency for Research
On Cancer (3.3: 1) [35], Hernandez-Guerrero et al. (1.4 : 1)
[34] and Ferlay et al. [36]. Most of the SCCs in the study
were distributed in the fifth and sixth decades of life,
and the average age was 51.2 years; this result was
largely compatible with the seventh and eighth decades
of life reported in a North American population [37,38].
The proportion of SCC in patients less than 40 years of
age was about 11% in this study, which was compatible
with the finding in Indians [39]; moreover, the trend of
patients of a younger age with oral cancer has also been
documented in the studies from Scotland [40] and the
UK [41].
Candidiasis comprised 6.8% of all HN lesions, which
was appeared to be higher than the result of Jones &
Franklin (1.0%) [6]. The male to female ratio of this le-
sion (3:1) in the cohort was seemed to be higher than
that of Jones & Franklin (1.69:1) [6]. Moreover, most
cases of candidiasis were located in the buccal mucosa
in the current study, followed by the tongue, which was
the same as the study of Ali & Sundaram [9]. Inflamma-
tion comprised 4.9% of all HN lesions, which was ap-
peared to be greater than the studies of Tay (3.6%) [11]
and Jones & Franklin (1.2%) [6]. Apical granuloma com-
prised 3.7% of all lesions, which was lower than the re-
sults of Bhaskar (12.0%) [10] and Tay (8.8%) [11]. Most
apical granulomas in the current cohort were located in
the maxilla, but no specific location has been reported
in other studies [5-11]. Exostosis and dense fibrotic den-
tal follicles were the two most common lesions in the
others/miscellaneous group, which mostly occurred inthe maxilla and were distributed in the sixth and second
decades of life.
Conclusion
The present study described in detail the frequency, age
and sex distribution in a cohort of Taiwanese patients re-
ferred for histopathological examination. It showed trends
similar to previous reports from other countries; however,
some detailed information was different, perhaps due to
the different criteria and different geographic distribution.
Moreover, oral SCC and oral potentially malignant dis-
orders comprised high percentages of all HN lesions in
the cohort; nevertheless it should be cautioned that the
sample being non-epidemiologic and would probably be
greatly askew to a high rate of malignant/potentially
malignant lesions when compared to an epidemiological
sample.
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